Home
Resources
Publications
Pharmacy Report: Megestrol Acetate-Induced Adrenal Insufficiency

Pharmacy Report: Megestrol Acetate-Induced Adrenal Insufficiency

Sowmya Nanjappa, Christy Thai, Sweta Shah, Matthew Snyder

Cancer Control. 2016 Apr;23(2):167-9.

PMID: 27218795

Abstract:

A man aged 65 years with metastatic renal cell carcinoma presented for evaluation after a recent fall. A thorough workup of the case was performed and secondary adrenal insufficiency induced by the administration of megestrol acetate was determined to be the cause. Adrenal insufficiency is a serious disorder that is a potential adverse event of megestrol acetate, a medication used to help patients with cancer cachexia increase their appetite and gain weight. This association is not well recognized in clinical practice, so this case highlights the importance of distinguishing possible endocrine complications induced by the long-term administration or sudden discontinuation of megestrol acetate.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP595335-B	Megestrol acetate		595-33-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: